For now, Australia's plans for cannabis market dominance are more smoke than fire

SYDNEY (Reuters) - When Australia said this month it would allow exports of medicinal cannabis in a bid to dominate a global market set to be worth $55 billion by 2025, investors scrambled to buy shares in marijuana companies - pushing several of them, and the sector as a whole, to record highs. But convoluted and restrictive licensing demands, substantial finance requirements and a guarded medical profession means even Australia’s largest marijuana companies are at least a year away from a c...